Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemostasis Network is a specialized clinical research organization (CRO) and site management organization (SMO) that focuses on the therapeutic areas of hemostasis and thrombosis. Headquartered in Ancaster, Ontario, the company provides a full suite of clinical trial services, including study design, site selection, and patient recruitment for global pharmaceutical and biotechnology clients. Hemostasis Network is particularly recognized for its expertise in managing trials for bleeding disorders like hemophilia and clotting conditions such as venous thromboembolism. By utilizing a dedicated network of specialized investigators and clinical sites, the organization streamlines the development process for novel anticoagulants and factor replacement therapies. Their deep clinical knowledge and focused operational approach make them a preferred partner for complex hematological research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemostasis Network.